AAC Accepts, published online ahead of print on 19 October 2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Xu, Y.
Right arrow Articles by Wang, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, Y.
Right arrow Articles by Wang, B.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.00714-09
Copyright (c) 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

In Vitro Activity of Thimerosal against Ocular Pathogenic Fungi

Yan Xu*, Guangren Pang, Dongqing Zhao, Chuanwen Gao, Lutan Zhou, Shengtao Sun, and Bingliang Wang

Henan Eye Institute, Department of Ophthalmology, Henan Provincial People's Hospital, Zhengzhou, China; and Anyang Eye Hospital, Anyang, China

* To whom correspondence should be addressed. Email: xuyan990301{at}yahoo.com.cn.


arrow
Abstract

The in vitro activity of thimerosal vs amphotericin B and natamycin was assessed against 244 ocular fungal isolates. The activity of thimerosal against Fusarium spp., Aspergillus spp. and Alternaria alternata was 256 times, 512 times and 128 times, respectively, greater than that of natamycin, 64 times, 32 times and 32 times, respectively, greater than amphotericin. Thimerosal's antifungal activity was significantly superior to those of amphotericin B and natamycin against ocular pathogenic fungi in vitro.






Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»